Bavarian Nordic A/S (OTCMKTS:BVNRY) Shares Pass Below 200 Day Moving Average - Time to Sell?

Shares of Bavarian Nordic A/S (OTCMKTS:BVNRY - Get Free Report) passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $9.25 and traded as low as $7.32. Bavarian Nordic A/S shares last traded at $7.34, with a volume of 1,963 shares changing hands.

Bavarian Nordic A/S Stock Up 1.3 %

The stock has a market capitalization of $1.75 billion, a P/E ratio of 10.73 and a beta of 1.83. The company has a 50 day moving average of $8.07 and a 200-day moving average of $9.22.

Bavarian Nordic A/S (OTCMKTS:BVNRY - Get Free Report) last posted its quarterly earnings results on Wednesday, March 5th. The company reported $0.47 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.40 by $0.07. Bavarian Nordic A/S had a net margin of 18.33% and a return on equity of 10.65%. The company had revenue of $299.48 million for the quarter, compared to the consensus estimate of $264.06 million. Equities analysts forecast that Bavarian Nordic A/S will post 0.67 EPS for the current fiscal year.

Bavarian Nordic A/S Company Profile

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.